Secteur Perspective Therapeutics, Inc.

Actions

CATX

US46489V3024

Recherche biotechnologique et médicale

Marché Fermé - NYSE 22:00:00 03/08/2026 Varia. 5j. Varia. 1 janv.
3,010 USD +3,44% Graphique intraday de Perspective Therapeutics, Inc. +6,74% +9,45%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+3,44%+6,74%-16,62%-24,37%+9,45%-22,62%-47,68%-55,48%-60,71% 332 M
-0,36%+2,23%-0,78%+16,90%+4,17%-2,06%+12,54%-21,58%+209,16% 48,53 Md
-2,71%-2,99%-3,97%+23,36%+129,06%+390,72%+472,12%+518,26% - 39,87 Md
-0,71%+9,45%+13,30%+45,00%+3,53%+27,69%+7,89%-6,65%+202,91% 38,68 Md
-0,71%-3,72%+1,39%+5,60%+3,28%+3,11%+52,45%-8,11%+1 080,03% 35,13 Md
-2,41%+2,59%+3,17%-4,58%+5,70%+11,68%+41,16%-15,90%+153,21% 29,79 Md
-0,66%-2,73%+1,45%+37,47%+2,07%+32,57%+122,17%+224,55% - 16,11 Md
-0,19%-3,93%-9,13%+6,44% - - - - - 16,08 Md
-0,62%+2,02%-2,02%+14,77%+8,56%+2,76%+14,08%-33,14%+80,74% 13,61 Md
-3,15%-6,14%-7,33%+41,48%-13,07%-3,88%-36,90%-35,10%+108,76% 12,62 Md
+0,07%+0,73%+1,72%+31,79%+22,67%+31,45%-10,95%-40,04%+156,16% 11,23 Md
-0,71%+2,93%-0,24%+33,98%+15,74%+37,49%+14,55%-43,86%+168,58% 11,2 Md
+0,94%-4,88%-16,04%+11,25%-10,88%+75,33%+536,42%+266,84%+2 418,78% 10,54 Md
+0,01%-0,13%+0,46%+60,51%+77,68%+260,12%+534,99% - - 10,07 Md
-1,98%-6,38%+23,91%+23,06%+26,87%+19,83%+28,50%-60,84% - 9,09 Md
-3,19%-2,42%+0,59%+32,92%+51,45%+145,74%+612,33%+168,53% - 8,79 Md
+5,25%-2,63%-34,49%-27,78%-31,12%+25,41%+38,23%+44,12%+44,42% 8,6 Md
-0,75%-3,26%-2,55%-9,51%+3,65%+497,98%+1 973,22%+37,43% - 8,58 Md
+2,25%+3,04%+8,12%+24,65%-10,58%-19,97%-18,67%-27,75%+37,34% 8,56 Md
-2,99%-8,85%-12,59%+20,00%+28,92%+129,75%+320,06%+67,18% - 8,51 Md
Moyenne -0,38%-0,96%-2,58%+18,15%+17,22%+86,48%+245,61%+54,36%+383,28% 17,3 Md
Moyenne pondérée par Capi. -0,73%+0,64%-0,20%+20,24%+22,65%+86,66%+185,02%+78,61%+405,53%
Recherche biotechnologique et médicale - Autres
  1. Bourse
  2. Actions
  3. Action CATX
  4. Secteur Perspective Therapeutics, Inc.